Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with genetically defined cancers driven by oncogenes activated by allosteric mutations.

Company Name

Black Diamond Therapeutics

Location

Cambridge, Massachusetts, USA, and Basel, Switzerland